1.
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia
by Ahmed, A.I.A
Psychopharmacology, 2015, Vol.232 (14), p.2587-2595
2.
Internet-purchased ibogaine toxicity confirmed with serum, urine, and product content levels
by O'Connell, Charles W., MD
The American journal of emergency medicine, 2014, Vol.33 (7), p.985.e5-985.e6
3.
MDMA: On the translation from rodent to human dosing
by Green, A. Richard
Psychopharmacology, 2009, Vol.204 (2), p.375-378
4.
Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial
by Mendelson, John E
Psychopharmacologia, 2010, Vol.214 (4), p.933-939
5.
MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function
by Kuypers, K.P.C
Psychopharmacologia, 2006, Vol.187 (4), p.467-475
6.
A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice
by Valjent, E
Psychopharmacology, 2000, Vol.147 (4), p.436-438
7.
Validation of Large White Pig as an animal model for the study of cannabinoids metabolism: Application to the study of THC distribution in tissues
by Brunet, Bertrand
Forensic science international, 2006, Vol.161 (2), p.169-174
8.
Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected
by Kuypers, K.P
Psychopharmacology, 2007, Vol.189 (4), p.557-563
9.
Stability of Delta(9)-tetrahydrocannabinol (THC) in oral fluid using the Quantisal collection device
by Moore, C
Forensic science international, 2006, Vol.164 (2-3), p.126
10.
Intracranial self-administration of MDMA into the ventral striatum of the rat: differential roles of the nucleus accumbens shell, core, and olfactory tubercle
by Shin, Rick
Psychopharmacologia, 2008, Vol.198 (2), p.261-270
11.
Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose
by PALENICEK, Tomas
Psychopharmacologia, 2007, Vol.196 (1), p.51-62
12.
Comment on the letter by Green, Gabrielsson, Marsden, and Fone, MDMA: on the translation from rodent to human dosing
by de la Torre, Rafael
Psychopharmacology, 2009, Vol.204 (2), p.379-380
13.
Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose
by Garcı́a-Repetto, R
Forensic science international, 2003, Vol.135 (2), p.110-114
14.
Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions
by Samyn, N
Forensic science international, 2002, Vol.128 (1-2), p.90-97
15.
Interactions between 3,4-methylenedioxymethamphetamine, methamphetamine, ketamine, and caffeine in human intestinal Caco-2 cells and in oral administration to rats
by Kuwayama, Kenji
Forensic science international, 2007, Vol.170 (2), p.183-188
16.
Interpretation of a 3,4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities
by De Letter, Els A
Forensic science international, 2004, Vol.141 (2-3), p.85-90
17.
Long-lasting effects of chronic stress on DOI-induced hyperthermia in male rats
by MATUSZEWICH, Leslie
Psychopharmacologia, 2003, Vol.169 (2), p.169-175
18.
Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses
by BERANKOVA, Katerina
Forensic science international, 2007, Vol.170 (2), p.94-99
19.
Fatal MDMA intoxication
by de la Torre, Rafael
The Lancet (British edition), 1999, Vol.353 (9152), p.593-593
20.
Hair analysis for Drug Abuse XV. Disposition of 3,4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse
by Kikura, Ruri
Forensic science international, 1997, Vol.84 (1), p.165-177
